Stakeholders discussed a cost board-backed proposal for a state healthcare transaction review program, comparing Oregon’s ability to deny transactions with California’s impact-review model and debating thresholds, expedited review for distressed hospitals, and funding via applicant fees.

Assistant chief counsel reported OKA has reviewed 45 material‑change notices since April 2024, waved many transactions, and expects AB1415 to increase filings from private equity, MSOs and newly created entities. Staff outlined recent notable waivers and timelines.